Condition: Non-valvular Atrial Fibrillation (AF) · Left Atrial Appendage Closure · Sponsor: Boston Scientific Corporation
The WATCHMAN FLX Pro European registry is intended to gather real world clinical data for patients undergoing left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro device. In a subregistry with approximately 300 patients, it is intended to use the VersaCross Connect™ LAAC Access Solution.
This description comes directly from the study's public registry record.
Thomas Näschen, PhD · +491707828594 · Thomas.Naeschen@bsci.com
Always discuss trial participation with your own doctor first.
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| Rigshospitalet Copenhagen | Copenhagen, Denmark | Recruiting |
| Kath Krankenhaus St Johann Nepomuk | Erfurt, Germany | Recruiting |
| Asklepios Klinik Saint Georg | Hamburg, Germany | Recruiting |
| Asklepios Klinik Nord Heidberg | Hamburg, Germany | Recruiting |
| Asklepios Klinik Altona | Hamburg, Germany | Recruiting |
| Centro Cardiologico Monzino | Milan, Italy | Recruiting |
| Uniwersytecki Szpital Kliniczny w Poznaniu | Poznan, Poland | Recruiting |
| Hospital de Leon | León, Spain | Recruiting |
| Clinica Universidad de Navarra | Pamplona, Spain | Recruiting |
| Complejo Hospitalario Universitario de Pontevedra | Pontevedra, Spain | Recruiting |
| Hospital Clinico Salamanca | Salamanca, Spain | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07262255